JennWell Women's Health

GLP-1 Weight Loss

Medical Weight Management for Women: Hormones, Metabolism and Medication

How a women's health clinician approaches weight medically — looking at insulin resistance, PCOS, perimenopause and medications — and how weight-management medicines fit alongside nutrition and activity under current guidelines.

Written & reviewed by Jennifer Neilan, WHNP

A medical approach, not another diet

For many women, weight is tangled up with hormones: PCOS, insulin resistance, perimenopause, postpartum changes and medications can all make weight harder to manage. A medical approach starts by understanding why your body is holding on to weight, then building a plan that is realistic and safe.

The evaluation

A first visit covers your weight history, eating patterns, sleep, stress, activity, menstrual history and medications. Labs may include blood sugar or A1c, lipids, thyroid testing, liver tests and, when indicated, PCOS-related labs. Blood pressure and waist measurement help assess metabolic risk. The 2023 International PCOS Guideline recommends metabolic screening for women with PCOS, and Endocrine Society guidance encourages reviewing medications that may promote weight gain and considering alternatives where possible.

Foundations that matter

Consensus guidelines consistently place nutrition, physical activity and behavior support at the center of weight management. For women in midlife, practical priorities include:

  • Adequate protein spread through the day to help preserve muscle
  • Strength training at least two days a week
  • Fiber-rich foods and fewer ultra-processed, high-sugar foods
  • Consistent sleep of seven or more hours when possible
  • Limiting alcohol, which affects sleep, appetite and hot flashes

Where medication fits

The Endocrine Society's clinical practice guideline supports adding weight-management medication for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or prediabetes, when lifestyle changes alone have not been enough. Newer medicines, including GLP-1–based treatments, can produce substantial weight loss for some patients. Whether a medication is appropriate depends on your health history, other medications, pregnancy plans, side effects and cost or insurance coverage.

For women with PCOS and insulin resistance, metformin may also be considered, as discussed in the 2023 International PCOS Guideline. Any weight-management medicine requires follow-up to monitor progress and side effects, and most are not used during pregnancy or when trying to conceive.

Hormones and midlife weight

Menopausal hormone therapy is not a weight-loss treatment. The Menopause Society notes it may help limit the shift of fat toward the abdomen in some women, and by improving sleep and hot flashes it can make healthy routines easier to maintain.

Ongoing support

Sustainable change takes time. Regular follow-up lets Jennifer Neilan, WHNP, adjust your plan, celebrate non-scale progress like better energy, blood sugar and blood pressure, and make sure treatment stays safe and aligned with your goals. JennWell offers GLP-1 medical weight loss with semaglutide or tirzepatide for women who qualify.

Preparing for your visit

Coming prepared helps you get the most from an appointment about medical weight management. Bring your weight history, recent labs, a list of medications, and any weight-management medicines you've tried. Note your pregnancy plans and what insurance you have.

JennWell Women's Health is located at 11844 Standing Stone Dr., Suite 200 in Gretna, inside Skilled Touch Health and Healing, and welcomes women from Elkhorn, West Omaha, Millard, Papillion, La Vista, Bennington, Lincoln and across Eastern Nebraska. To schedule, call (402) 800-8595 or request an appointment online. If you are unsure whether this service is right for you, a consultation is a no-pressure place to start the conversation and learn your options.

Frequently asked questions

Clinical guidelines & references

This guide is informed by published consensus statements from these professional organizations. It is educational and not a substitute for individual medical advice.

  1. American Gastroenterological Association (AGA). AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology. 2022;163(5):1198–1225.
  2. Endocrine Society. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(2):342–362.
  3. American Association of Clinical Endocrinology (AACE). Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3):1–203.
  4. Monash University, ASRM, ESHRE & Endocrine Society (co-endorsed). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–2469.
  5. The Menopause Society (formerly NAMS). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767–794.

Ready for care that listens?

Book an unhurried visit with Jennifer Neilan, WHNP, in Gretna — serving Omaha and Eastern Nebraska.